Enabling Cytokine Therapeutic Development with Qualified, Functional Cell-Based Assays – from Screening to QC Lot Release

Time: 10:00 am


• Discover how cell-based assays and translational services accelerate cytokine-based
immunotherapeutic development from early discovery to GMP Lot Release Testing
• Learn about industry’s largest cell-based assay portfolio covering 80+ cytokine,
interleukin and chemokine targets including IL-1, IL-2, IL-6, IL-7, IL-12, IL-15, IL-17,
• Delve into custom bioassay qualification case studies showing development of
fit-for-purpose bioassays for potency, stability, and NAb testing
• Learn how method transfer support is critical for assay implementation at CRO sites
• Gain human insights early, with custom biomarker services and the BioMAP®
Platform of cell-based disease models